CONMED exec exercises RSUs, updates share holdings

CONMED Corp executive Brent Lalomia exercised restricted stock units and received additional common shares as compensation.

Rhea-AI Filing Summary

CONMED Corp executive Brent Lalomia exercised restricted stock units and received additional common shares as compensation. On March 6, 2026, 75 RSUs converted into 75 shares of common stock, and 26 of those shares were withheld at a price of $39.90 per share to cover tax obligations. After these transactions, Lalomia directly held 915.057 shares of CONMED common stock. A footnote also clarifies that prior reported holdings have been adjusted to exclude 140 shares that were previously reported in error.

Insider Trade Summary

75 shares exercised/converted

Exercise 3 txns

Insider Lalomia Brent

Role Executive VP RA, QA

Type	Security	Shares	Price	Value
Exercise	RSUs (Restricted Stock Units)	75	$0.00	$0.00
Exercise	Common Stock	75	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	26	$39.90	$1K

Holdings After Transaction: RSUs (Restricted Stock Units) — 0 contracts (Direct); Common Stock — 915.057 shares (Direct)

Footnotes (2)

1. F1. The number of shares beneficially owned by the reporting person has been adjusted to exclude 140 shares that were incorrectly reflected in prior reports.
2. F2. Represents the settlement of vested restricted stock units (RSUs) with the delivery of shares of common stock, subject to withholding for taxes. Each RSU represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CONMED (CNMD) executive Brent Lalomia report?

Brent Lalomia reported exercising 75 restricted stock units into 75 CONMED common shares. As part of this compensation-related event, some shares were withheld for taxes, and his directly held position was updated in the filing.

How many CONMED (CNMD) shares did Brent Lalomia receive and retain after the RSU settlement?

Lalomia’s 75 RSUs settled into 75 CONMED common shares. After 26 shares were withheld at $39.90 each for taxes, the filing reports that he directly held 915.057 CONMED common shares following the transactions.

What does the tax withholding transaction mean in the CONMED (CNMD) Form 4?

The Form 4 shows 26 CONMED shares withheld at $39.90 each to satisfy tax obligations on the RSU settlement. This F-code transaction is not an open-market sale, but an automatic share disposition to cover required taxes.

Were any open-market purchases or sales reported by Brent Lalomia of CONMED (CNMD)?

The filing shows an RSU exercise and a related tax withholding, but no open-market purchases or sales. The reported M and F codes reflect compensation-related share delivery and tax settlement rather than discretionary trading in the market.

How were Brent Lalomia’s previously reported CONMED (CNMD) share holdings corrected?

A footnote explains that Lalomia’s beneficial ownership number was adjusted to remove 140 CONMED shares previously reported in error. The updated figure in this Form 4 is intended to more accurately reflect his current direct share holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/10/2026 - 02:40 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lalomia Brent

(Last) (First) (Middle)

C/O CONMED CORPORATION

11311 CONCEPT BOULEVARD

(Street)

LARGO FL 33773

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CONMED Corp [ CNMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive VP RA, QA

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/06/2026		M		75	A	$0	941.057(1)	D
Common Stock	03/06/2026		F		26	D	$39.9	915.057	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
RSUs (Restricted Stock Units)	$0	03/06/2026		M			75	(2)	03/07/2032	Common Stock	75	$0	0	D

Explanation of Responses:

1. The number of shares beneficially owned by the reporting person has been adjusted to exclude 140 shares that were incorrectly reflected in prior reports.

2. Represents the settlement of vested restricted stock units (RSUs) with the delivery of shares of common stock, subject to withholding for taxes. Each RSU represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation.

	/s/ Thomas Fistek for Brent Lalomia by Power of Attorney	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.